The new rule highlights how governments are reassessing their reliance on India#39;s $42 billion pharmaceutical industry since the contamination came to light last year.
The new rule highlights how governments are reassessing their reliance on India#39;s $42 billion pharmaceutical industry since the contamination came to light last year. The new rule highlights how governments are reassessing their reliance on India#39;s $42 billion pharmaceutical industry since the contamination came to light last year. Moneycontrol Latest News Read More
English 
हिन्दी